Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 4,390 |
| Receivables | 50 |
| Other current assets | 110 |
| TOTAL | $4,550 |
| Non-Current Assets | |
| PPE Net | 10,930 |
| Other Non-Current Assets | 700 |
| TOTAL | $11,630 |
| Total Assets | $10,680 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 750 |
| Accrued Expenses | 2,170 |
| TOTAL | $2,920 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 1,650 |
| TOTAL | $1,650 |
| Total Liabilities | $4,580 |
| Shareholders' Equity | |
| Common Shares | 3 |
| Retained earnings | -53,110 |
| Other shareholders' equity | 58,167 |
| TOTAL | $6,100 |
| Total Liabilities And Equity | $10,680 |